The Desmoid Tumor Research Foundation

July 2017

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

Author Information

Penel N(1), Le Cesne A(2), Bonvalot S(3), Giraud A(4), Bompas E(5), Rios M(6), Salas S(7), Isambert N(8), Boudou-Rouquette P(9), Honore C(2), Italiano A(10), Ray-Coquard I(11), Piperno-Neumann S(12), Gouin F(13), Bertucci F(14), Ryckewaert T(15), Kurtz JE(16), Ducimetiere F(11), Coindre JM(17), Blay JY(11)

(1)Medical Oncology Department, Centre Oscar Lambret, Lille, France. Electronic address: n-penel@o-lambret.fr.(2)Department of Medical Oncology & Surgery, Institut Gustave Roussy, Villejuif, France.(3)Department of Surgery, Curie Institute, Paris, France.(4)Clinical and Epidemiological Research Unit, Institut Bergonie, Inserm CIC1401,Bordeaux, France.(5)Medical Oncology Department, Rene Gauducheau, Saint-Herblain, France.(6)Medical Oncology Department, Centre Alexis Vautrin, Nancy, France.(7)Medical Oncology Department, CH La Timone, Marseille, France.(8)Medical Oncology Department, Centre GF Leclerq, Dijon, France.(9)Department of Medical Oncology, CERIA, Paris Descartes University, AP-HP, Cochin Hospital, Paris, France.(10)Medical Oncology Department, Bergonie Institute, Bordeaux, France.(11)Centre Leon Berard Lyon and Universite Claude Bernard Lyon I, Lyon, France.(12)Department of Medical Oncology, Institut Curie, Paris, France.(13)CHU Hotel-Dieu, Nantes, France; INSERM UI957, Nantes, France.(14)Medical Oncology Department, Institut Paoli-Calmette, Marseille, France.(15)Medical Oncology Department, Centre Oscar Lambret, Lille, France.(16)Department of Medical Oncology and Hematology, Hopitaux Civils Universitaires Strasbourg, Strasbourg, France.(17)Department of Pathology, Institut Bergonie, Bordeaux, France.

Publication

Eur J Cancer

Summary

The outcome of desmoid-type fibromatosis (DTF) is unpredictable. Currently, a wait-and-see approach tends to replace large en bloc resection as the first therapeutic approach. Nevertheless, there are no validated factors to guide the treatment choice. We conducted a prospective study of 771 confirmed cases of DTF. We analysed event-free survival (EFS) based on the occurrence of relapse after surgery, progressive disease during the wait-and-see approach, or change in therapeutic strategy.

View Abstract